Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and Siltuximab Intravenous
Determining the interaction of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and Siltuximab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets, and Dasabuvir
Generic Name: siltuximab
Brand name: Sylvant
Synonyms: Siltuximab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Silvadene
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Silvadene Topical
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-SilvaSorb
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Silver
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Silver Nitrate
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Silver Nitrate Applicators
- Siltuximab Intravenous-Omeclamox-Pak
- Siltuximab Intravenous-Omega-3 Fatty Acid Capsules
- Siltuximab Intravenous-Omega-3 Fatty Acids
- Siltuximab Intravenous-Omega-3 polyunsaturated fatty acids
- Siltuximab Intravenous-Omega-3-acid ethyl esters
- Siltuximab Intravenous-Omega-3-carboxylic acids